Literature DB >> 23907596

TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.

Jung-A Choi1, In Kyoung Lim.   

Abstract

PURPOSE: Invasion of cancer cells depends on the proteolytic degradation of extracellular matrix regulated by actin-driven membrane protrusions, called invadopodia. However, the mechanisms underlying invadopodia formation in cancer cells remain largely unknown.
METHODS: By employing adenoviral transduction of breast cancer cells with either β-galactosidase (Ad-LacZ) or TIS21(/BTG2/Pc3) (Ad-TIS21) gene, the regulation of invadopodia formation was investigated. Invasion activity was examined by invadopodia assay and Matrigel assay. Intracellular reactive oxygen species (ROS) was monitored by FACS-based analysis.
RESULTS: Here, we observed that TIS21 suppressed invadopodia formation as well as invasion activity along with F-actin remodeling. The inhibition of TIS21-mediated invadopodia formation was accompanied with attenuation of ROS generation in the TIS21 expressers, indicating that TIS21-mediated inhibition of ROS plays a critical role for invadopodia formation by regulating actin-associated protein remodeling. This was further confirmed in the TIS21(-/-)MEF cells.
CONCLUSIONS: This is the first report to provide insight into invasion signals regulated by tumor suppressor, TIS21(/BTG2/Pc3) gene, in the intractable breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907596     DOI: 10.1007/s00432-013-1484-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters.

Authors:  B S Fletcher; R W Lim; B C Varnum; D A Kujubu; R A Koski; H R Herschman
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

2.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 3.  Cell migration in tumors.

Authors:  Hideki Yamaguchi; Jeffrey Wyckoff; John Condeelis
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  Twist1-induced invadopodia formation promotes tumor metastasis.

Authors:  Mark A Eckert; Thinzar M Lwin; Andrew T Chang; Jihoon Kim; Etienne Danis; Lucila Ohno-Machado; Jing Yang
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

5.  Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.

Authors:  Hirofumi Kawakubo; Elena Brachtel; Tetsu Hayashida; Giminna Yeo; Joshua Kish; Alona Muzikansky; Paul D Walden; Shyamala Maheswaran
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

6.  Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines.

Authors:  I K Lim; M S Lee; S H Lee; N K Kim; I Jou; J S Seo; S C Park
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  The humoral immune system has a key prognostic impact in node-negative breast cancer.

Authors:  Marcus Schmidt; Daniel Böhm; Christian von Törne; Eric Steiner; Alexander Puhl; Henryk Pilch; Hans-Anton Lehr; Jan G Hengstler; Heinz Kölbl; Mathias Gehrmann
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.

Authors:  Tae Jun Park; Ji Yeon Kim; S Paul Oh; So Young Kang; Bong Wan Kim; Hee Jung Wang; Kye Yong Song; Hyoung Chin Kim; In Kyoung Lim
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 9.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion.

Authors:  Paola Chiarugi; Giovambattista Pani; Elisa Giannoni; Letizia Taddei; Renata Colavitti; Giovanni Raugei; Mark Symons; Silvia Borrello; Tommaso Galeotti; Giampietro Ramponi
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

View more
  8 in total

1.  TIS21/BTG2 inhibits breast cancer growth and progression by differential regulation of mTORc1 and mTORc2-AKT1-NFAT1-PHLPP2 signaling axis.

Authors:  Santhoshkumar Sundaramoorthy; Preethi Devanand; Min Sook Ryu; Kye Yong Song; Dong Young Noh; In Kyoung Lim
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-28       Impact factor: 4.553

2.  Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.

Authors:  J-A Choi; Y S Jung; J Y Kim; H M Kim; I K Lim
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

Review 3.  Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis.

Authors:  Robert J Eddy; Maxwell D Weidmann; Ved P Sharma; John S Condeelis
Journal:  Trends Cell Biol       Date:  2017-04-12       Impact factor: 20.808

4.  Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.

Authors:  Helena Motaln; Ana Koren; Kristina Gruden; Živa Ramšak; Christian Schichor; Tamara T Lah
Journal:  Oncotarget       Date:  2015-12-01

5.  Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.

Authors:  Preethi Devanand; Santhoshkumar Sundaramoorthy; Min Sook Ryu; Aravinth Kumar Jayabalan; Takbum Ohn; In Kyoung Lim
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

6.  Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species.

Authors:  Sung-Gook Cho; Sang-Mi Woo; Seong-Gyu Ko
Journal:  J Exp Clin Cancer Res       Date:  2014-06-11

7.  PPARα-Target Gene Expression Requires TIS21/BTG2 Gene in Liver of the C57BL/6 Mice under Fasting Condition.

Authors:  Allen Eugene Hong; Min Sook Ryu; Seung Jun Kim; Seung Yong Hwang; In Kyoung Lim
Journal:  Mol Cells       Date:  2018-01-29       Impact factor: 5.034

8.  Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression.

Authors:  Preethi Devanand; Yukiko Oya; Santhoshkumar Sundaramoorthy; Kye Yong Song; Tatsuro Watanabe; Yasuhito Kobayashi; Yoshihiko Shimizu; Soon Auck Hong; Masami Suganuma; In Kyoung Lim
Journal:  Exp Mol Med       Date:  2018-02-23       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.